Cerebral venous thrombosis (CVT) is a potentially life-threatening condition requiring rapid diagnosis and urgent treatment. Heparin anticoagulation is the time-honoured treatment, and is advocated in all cases of CVT, irrespective of etiology or presence of haemorrhage. The supportive evidence is largely observational; data from randomized placebo-controlled trials shows a nonsignificant trend favouring heparin. Current practice is to begin heparin (unfractionated or low-molecular weight) immediately on confirmation of the diagnosis. Newer antithrombotic agents such as ximelagatran may offer advantages over heparin and need to be investigated in the treatment of CVT.
Publication ( Name of Journal)
JPMA. The Journal of the Pakistan Medical Association
(2006). Heparin in the treatment of cerebral venous thrombosis.. JPMA. The Journal of the Pakistan Medical Association, 56(11), 541-543.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_med/401
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.